期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Deep learning echocardiographic intelligent model for evaluation on left ventricular regional wall motion abnormality
1
作者 WANG Yonghuai DONG Tianxin MA Chunyan 《中国医学影像技术》 CSCD 北大核心 2024年第8期1135-1139,共5页
Objective To observe the value of deep learning echocardiographic intelligent model for evaluation on left ventricular(LV)regional wall motion abnormalities(RWMA).Methods Apical two-chamber,three-chamber and four-cham... Objective To observe the value of deep learning echocardiographic intelligent model for evaluation on left ventricular(LV)regional wall motion abnormalities(RWMA).Methods Apical two-chamber,three-chamber and four-chamber views two-dimensional echocardiograms were obtained prospectively in 205 patients with coronary heart disease.The model for evaluating LV regional contractile function was constructed using a five-fold cross-validation method to automatically identify the presence of RWMA or not,and the performance of this model was assessed taken manual interpretation of RWMA as standards.Results Among 205 patients,RWMA was detected in totally 650 segments in 83 cases.LV myocardial segmentation model demonstrated good efficacy for delineation of LV myocardium.The average Dice similarity coefficient for LV myocardial segmentation results in the apical two-chamber,three-chamber and four-chamber views was 0.85,0.82 and 0.88,respectively.LV myocardial segmentation model accurately segmented LV myocardium in apical two-chamber,three-chamber and four-chamber views.The mean area under the curve(AUC)of RWMA identification model was 0.843±0.071,with sensitivity of(64.19±14.85)%,specificity of(89.44±7.31)%and accuracy of(85.22±4.37)%.Conclusion Deep learning echocardiographic intelligent model could be used to automatically evaluate LV regional contractile function,hence rapidly and accurately identifying RWMA. 展开更多
关键词 ventricular function left systolic function ECHOCARDIOGRAPHY deep learning
下载PDF
中药联合艾司洛尔对脓毒症患者心肌抑制的干预效果分析 被引量:2
2
作者 黄柏文 《蛇志》 2017年第2期146-147,171,共3页
目的探讨中药联合β受体阻滞剂艾司洛尔对脓毒症患者心肌抑制的干预效果。方法将2014年1月~2017年1月符合脓毒症诊断的患者106例,采用随机数字表法分为中药联合艾司洛尔组(53例)和对照组(53例)。对照组按照脓毒症休克指南常规治疗,并给... 目的探讨中药联合β受体阻滞剂艾司洛尔对脓毒症患者心肌抑制的干预效果。方法将2014年1月~2017年1月符合脓毒症诊断的患者106例,采用随机数字表法分为中药联合艾司洛尔组(53例)和对照组(53例)。对照组按照脓毒症休克指南常规治疗,并给与艾司洛尔干预;中药联合艾司洛尔组在对照组的基础上,给予中药参松养心胶囊治疗。两组均治疗1周后,分别测定治疗前和治疗后患者血清心肌肌钙蛋白Ⅰ(cTnⅠ)浓度,并通过超声心动图随访评价两组患者治疗后心功能,比较主要心血管事件(MACE)的发生情况。结果中药联合艾司洛尔组治疗后cTnⅠ水平明显低于对照组(P<0.05),而且治疗后cTnI>0.10μg/L患者的比例明显低于对照组(P<0.01)。随访1个月后,中药联合艾司洛尔组患者左心室收缩末内径低于对照组(P<0.05),左心室射血分数高于对照组(P<0.01);两组MACE发生率比较,差异无统计学意义。结论中药联合艾司洛尔组可以减少心肌抑制,提高心肌功能,治疗后长期服用可以改善患者的左心室功能。 展开更多
关键词 脓毒症 艾司洛尔 Β受体阻滞剂 肌钙蛋白 肌抑制 心左室功能
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部